|
Routes of Administration, Ingredients,
Dispensing Status: for the veterinary drug: Dexdomitor, Orion,
Definition of medical terminology for Patent.
Blood Availability and Safety Inventory System (HHS)
A drug or medicine given to reduce pain without resulting in loss of consciousness.
Definition of medical terminology for Procedures, Minor Surgical.
Definition of medical terminology for Dexmedetomidine.
Definition of medical terminology for Medetomidine.
Definition of medical terminology for Product Container.
Definition of medical terminology for Dexmedetomidine.
Definition of medical terminology for Dexmedetomidine.
Definition of medical terminology for Hydrochloride Aspartic Acid.
Definition of medical terminology for Intravenous Injection.
Definition of medical terminology for Intramuscular Injection.
Definition of medical terminology for Injection Analyses, Flow.
A drug or medicine given to reduce pain without resulting in loss of consciousness.
Definition of medical terminology for Procedures, Minor Surgical.
Definition of medical terminology for Intramuscular Injection.
Definition of medical terminology for Injection Analyses, Flow.
The situation that occurs when a patient under general anesthesia becomes aware of some or all events during surgery or a procedure, and has direct recall of those events.
Definition of medical terminology for Intramuscular Injection.
Definition of medical terminology for Injection Analyses, Flow.
A drug or medicine given to reduce pain without resulting in loss of consciousness.
Definition of medical terminology for Procedures, Minor Surgical.
Definition of medical terminology for Veterinarian.
Definition of medical terminology for Food.
Dexdomitor® Sponsor Orion, Corp. Sponsor Address: Orionintie 1 Espoo, 02200 Finland Ingredients: Dexmedetomidine hydrochloride Species: Cat, no use class stated or implied Dog, no use class stated or implied Routes of Administration: Intravenous Intramuscular Dose Form: Liquid (solution) Drug Form: Liquid (solution) Dispensing Status: RX Patent Number: 4910214 Exclusivity Exclusivity granted on the basis of a supplemental approval for the drug`s use in cats as a sedative and analgesic to facilitate clinical examination, clinical procedures, minor surgical procedures, and minor dental procedures. Exclusivity granted because dexmedetomidine is a new compound, the dextrorotary enantiomer of the approved racemic compound medetomidine. Withdrawal Time: Withdrawal times do not apply to the Species: listed for this product . Dosage Amount, Indications & Limitations: 522.558 Dexmedetomidine. Specifications: Each milliliter of solution contains 10 milligrams (mg) dexmedetomidine hydrochloride . Conditions of use: Dogs Amount: Administer 375 micrograms (?g) per square meter (/m2) of body surface area by intravenous injection or 500 ?g/m2 of body surface area by intramuscular injection . Indications: For use as a sedative and analgesic in dogs to facilitate clinical examinations, clinical procedures, minor surgical procedures, and minor dental procedures. Amount: Administer 125 ?g/m2 of body surface area or 375 ?g/m2 of body surface area by intramuscular injection . Indications: For use as a preanesthetic to general anesthesia . Cats Amount: 40 ?g/kilogram by intramuscular injection . Indications: For use as a sedative and analgesic to facilitate clinical examinations, clinical procedures, minor surgical procedures, and minor dental procedures. Limitations: Federal law restricts this drug to use by or on the order of a licensed veterinarian. U.S. Food and Drug Administration: 5600 Fishers LaneRockville, MD 20857-0001; 1-888-INFO-FDA (1-888-463-6332)
|
